Summary
HCA Healthcare, Inc. (HCA) has announced the completion of a significant debt offering, raising $5.25 billion in aggregate principal amount of senior notes through its wholly owned subsidiary, HCA Inc. This offering comprises six tranches with varying maturities and interest rates, including senior notes due 2028, 2030, 2032, 2035, and 2055, as well as floating rate senior notes due 2028. These notes are guaranteed on a senior unsecured basis by HCA Healthcare, Inc. and are intended to provide additional financial flexibility for the company. The issuance was completed on February 21, 2025, under the company's existing shelf registration statement and pursuant to multiple supplemental indentures. The specific terms, including interest rates and payment dates, are detailed for each tranche. The notes rank senior to subordinated debt and equally to other senior indebtedness of the Issuer, but are effectively subordinated to secured debt and structurally subordinated to the debt of HCA's subsidiaries. Covenants within the indentures place limitations on liens, sale-leaseback transactions, and asset disposals. Additionally, provisions for optional redemption, change of control triggers with a repurchase price of 101%, and events of default are outlined.
Key Highlights
- 1HCA Inc. successfully issued $5.25 billion in aggregate principal amount of senior notes.
- 2The offering includes multiple tranches with maturities ranging from 2028 to 2055, and a floating rate note option.
- 3HCA Healthcare, Inc. provides a senior unsecured guarantee for all notes issued by its subsidiary.
- 4The notes are senior unsecured obligations, ranking equally with other senior debt but subordinated to secured debt and subsidiary debt.
- 5The company has incorporated covenants to limit liens, sale-leaseback transactions, and asset disposals.
- 6A change of control provision requires HCA to repurchase notes at 101% of principal plus accrued interest under specific conditions (qualifying ratings downgrade and change of control).